 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
July 5, 2007
Cell Therapeutics
Seattle-based biopharmaceutical company Cell Therapeutics hired Dr. Jay Umbreit as medical director of the XYOTAX/CT-2103 program in the Clinical Department. Umbreit has been a professor at University of South Alabama and Emory University in Atlanta. XYOTAX is a chemotherapeutic drug candidate for treating lung and ovarian cancers in women.